B
BioCryst Pharmaceuticals, Inc. (BCRX)
NMS – Real Time Price. Currency in USD
8.80
+0.22 (2.56%)
At close: May 12, 2026, 4:00 PM EDT
8.87
+0.07 (0.80%)
After-hours: May 12, 2026, 7:40 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
8.80
+0.22 (2.56%)
At close: May 12, 2026, 4:00 PM EDT
8.87
+0.07 (0.80%)
After-hours: May 12, 2026, 7:40 PM EDT
No Data
There are no news for this stock.
Total debt $858.1M significantly exceeds cash reserves ($172.4M), raising financial stability concerns
Total current assets $373.6M exceed Total current liabilities $195.4M, highlighting excellent liquidity
Debt-to-equity ratio (-1.5) is well below the industry average (-0.8), showcasing prudent financial management
Interest coverage ratio (-0.2x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$62.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.91 | 2.52 | 9.0 | |
| Quick ratio | 1.88 | 1.78 | 9.0 | |
| Debt to Equity | N/A | -0.80 | 1.0 | |
| Debt to Assets | 1.85 | 0.73 | 1.0 | |
| Interest coverage | -0.19 | -13.90 | 1.0 | |
| Weighted average score | 4.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 271M | 331M | 451M | 875M | 886M |
| Gross Profit | 263M | 325M | 437M | 854M | 864M |
| Operating Income | -148M | -104M | -3M | 341M | 316M |
| Net Income | -247M | -227M | -89M | 264M | -458M |
| EBITDA | -147M | -102M | -1M | 342M | 318M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 13.67 | 544.44 | 9.0 |
| Next quarter | 4.21 | -29.63 | 2.5 |
| Current year | -23.3 | -292.05 | 1.0 |
| Next year | 8.37 | 114.92 | 8.0 |
| Weighted average score | 5.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -61.52 | -393.59 | -366.06 | -122.71 | 1.0 |
| Y/Y | 7.48 | -2255762.49 | 999 | -121.95 | 4.3 |
| 3y average | 50.82 | 155.32 | 152.08 | 267.28 | 10 |
| 5y average | 201.43 | 86.21 | 86.52 | 156.8 | 10 |
| Weighted average score | 6.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |